The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica
Open accessAbstract
Objective: Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system. Circulating autoantibodies (NMO‐immunoglobulin [Ig]G) against astrocyte water channel aquaporin‐4 (AQP4) cause complement‐ and cell‐mediated astrocyte damage with consequent neuroinflammation and demyelination. Current NMO therapies, which have limited efficacy, include immunosuppression and plasma exchange. The objective of this study was to develop a potential new NMO therapy based on blocking of pathogenic NMO‐IgG binding to its target, AQP4. Methods: We generated nonpathogenic recombinant monoclonal anti‐AQP4 antibodies that selectively block NMO‐IgG binding to AQP4. These antibodies comprise a tight‐binding anti‐AQP4 Fab and a mutated Fc that lacks functionality for complement‐ and cell‐mediated cytotoxicity. The efficacy of the blocking antibodies was studied using cell culture, spinal cord slice, and in vivo mouse models of NMO. Results: In AQP4‐expressing cell cultures, the nonpathogenic competing antibodies blocked binding of NMO‐IgG in human sera, reducing to near zero complement‐ and cell‐mediated cytotoxicity. The antibodies prevented the development of NMO lesions in an ex vivo spinal cord slice model of NMO and in an in vivo mouse model, without causing cytotoxicity. Interpretation: Our results provide proof of concept for a therapy of NMO with blocking antibodies. The broad efficacy of antibody inhibition is likely due to steric competition because of its large physical size compared to AQP4. Blocker therapy to prevent binding of pathogenic autoantibodies to their targets may be useful for treatment of other autoimmune diseases as well. ANN NEUROL 2012;
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Self-citationThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
Manley, G. T., Fujimura, M., Ma, T., Noshita, N., Filiz, F., Bollen, A. W., Chan, P., & Verkman, A. S. (2000) · Nature Medicine · doi:10.1038/72256 · Cited by 1,507
Self-citationNielsen, S., Arnulf Nagelhus, E., Amiry-Moghaddam, M., Bourque, C., Agre, P., & Petter Ottersen, O. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00171.1997 · Cited by 1,442
Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema
Papadopoulos, M. C., Manley, G. T., Krishna, S., & Verkman, A. S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1723fje · Cited by 749
Self-citationIntrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Self-citationThe binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Self-citationPathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Involvement of aquaporin-4 in astroglial cell migration and glial scar formation
Saadoun, S., Papadopoulos, M. C., Watanabe, H., Yan, D., Manley, G. T., & Verkman, A. S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02680 · Cited by 464
Self-citationEFNS guidelines on diagnosis and management of neuromyelitis optica
Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sorensen, P. S., & Hemmer, B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03066.x · Cited by 461
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 423
Hinson, S. R., Roemer, S. F., Lucchinetti, C. F., Fryer, J. P., Kryzer, T. J., Chamberlain, J. L., Howe, C. L., Pittock, S. J., & Lennon, V. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081241 · Cited by 355
Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin‐4 water channels
Binder, D. K., Yao, X., Zador, Z., Sick, T. J., Verkman, A. S., & Manley, G. T. (2006) · Glia · doi:10.1002/glia.20318 · Cited by 352
Self-citationMechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A., & Wildemann, B. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0764 · Cited by 335
Hezareh, M., Hessell, A. J., Jensen, R. C., van de Winkel, J. G. J., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12161-12168.2001 · Cited by 294
Engineered Antibodies with Increased Activity to Recruit Complement
Idusogie, E. E., Wong, P. Y., Presta, L. G., Gazzano-Santoro, H., Totpal, K., Ultsch, M., & Mulkerrin, M. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2571 · Cited by 291
Neuromyelitis optica: Passive transfer to rats by human immunoglobulin
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.085 · Cited by 249
Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
Kontermann, R. E. (2009) · BioDrugs · doi:10.2165/00063030-200923020-00003 · Cited by 243
Auguste, K. I., Jin, S., Uchida, K., Yan, D., Manley, G. T., Papadopoulos, M. C., & Verkman, A. S. (2007) · The FASEB Journal · doi:10.1096/fj.06-6848com · Cited by 224
Self-citationK+ waves in brain cortex visualized using a long-wavelength K+-sensing fluorescent indicator
Padmawar, P., Yao, X., Bloch, O., Manley, G. T., & Verkman, A. S. (2005) · Nature Methods · doi:10.1038/nmeth801 · Cited by 216
Self-citationCrane, J. M., Lam, C., Rossi, A., Gupta, T., Bennett, J. L., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227298 · Cited by 197
Self-citationProinflammatory role of aquaporin‐4 in autoimmune neuroinflammation
Li, L., Zhang, H., Varrin-Doyer, M., Zamvil, S. S., & Verkman, A. S. (2011) · The FASEB Journal · doi:10.1096/fj.10-177279 · Cited by 190
Self-citationOligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
Marignier, R., Nicolle, A., Watrin, C., Touret, M., Cavagna, S., Varrin-Doyer, M., Cavillon, G., Rogemond, V., Confavreux, C., Honnorat, J., et al. (2010) · Brain · doi:10.1093/brain/awq177 · Cited by 183
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Zhang, H., Bennett, J. L., & Verkman, A. S. (2011) · Annals of Neurology · doi:10.1002/ana.22551 · Cited by 168
Self-citationPatterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
Mader, S., Lutterotti, A., Pauli, F. D., Kuenz, B., Schanda, K., Aboul‐Enein, F., Khalil, M., Storch, M. K., Jarius, S., Kristoferitsch, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010455 · Cited by 160
Mammalian aquaporins: diverse physiological roles and potential clinical significance
Verkman, A. S. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000690 · Cited by 150
Self-citationEngineering the variable region of therapeutic IgG antibodies
Igawa, T., Tsunoda, H., Kuramochi, T., Sampei, Z., Ishii, S., & Hattori, K. (2011) · mAbs · doi:10.4161/mabs.3.3.15234 · Cited by 143
Parratt, J. D. E., & Prineas, J. W. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510382324 · Cited by 143
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution
Bizzoco, E., Lolli, F., Repice, A. M., Hakiki, B., Falcini, M., Barilaro, A., Taiuti, R., Siracusa, G., Amato, M. P., Biagioli, T., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5171-x · Cited by 135
Hinson, S. R., McKeon, A. B., Fryer, J. P., Apiwattanakul, M., Lennon, V. A., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.188 · Cited by 124
Optimizing Therapeutic Antibody Function: Progress with Fc Domain Engineering
Kaneko, E., & Niwa, R. (2010) · BioDrugs · doi:10.2165/11537830-000000000-00000 · Cited by 63
Neuromyelitis optica: Diagnosis, pathogenesis, and treatment
Cree, B. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0066-2 · Cited by 60
Saadoun, S., Waters, P. J., Macdonald, C., Bridges, L., Bell, B. A., Vincent, A. C., Verkman, A. S., & Papadopoulos, M. C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.007 · Cited by 41
Self-citationBaudino, L., Nimmerjahn, F., Shinohara, Y., Furukawa, J., Petry, F., Verbeek, J. S., Nishimura, S., Ravetch, J. V., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4107 · Cited by 19
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Aquaporin water channels in the nervous system
Papadopoulos, M. C., & Verkman, A. S. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3468 · Cited by 741
Self-citationSchwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Self-citation
Metadata
- Authors
- Tradtrantip, L., Zhang, H., Saadoun, S., Phuan, P., Lam, C., Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-01-23
- Volume
- 71
- Issue
- 3
- Pages
- 314-322
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2171013521
- Cited by
- 253
- References
- 38
- FWCI
- 18.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.